Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (431-440 of 663) with videos related to

Pageof 67
Sort By:
Immunity|November 29, 2024
Cognate antigen engagement induces HIV-1 expression in latently infected CD4<sup>+</sup> T cells from people on long-term antiretroviral therapyMilica Moskovljevic, Filippo Dragoni, Nathan L Board, et al.
Ebiomedicine|March 1, 2021
Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latencyJennifer M Zerbato, Georges Khoury, Wei Zhao, et al.
Nature Immunology|January 26, 2024
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cellsNathan L Board, Zhe Yuan, Fengting Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2012
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?Amy C Justice, Matthew S Freiberg, Russ Tracy, et al.
Plos One|December 30, 2014
The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trialMa Somsouk, Richard M Dunham, Michelle Cohen, et al.
The Journal of Infectious Diseases|September 12, 2022
Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVIDMichael J Peluso, Anthea Mitchell, Chung Yu Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative studyEdda I Santiago-Rodriguez, Andres Maiorana, Michael J Peluso, et al.
Frontiers in Immunology|August 15, 2022
Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIVMichael L Freeman, Brian M Clagett, Daniela Moisi, et al.
The Journal of Infectious Diseases|April 29, 2017
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral TherapyGabriela Khoury, Rémi Fromentin, Ajantha Solomon, et al.
Nature Medicine|June 25, 2013
Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune controlSrinika Ranasinghe, Sam Cutler, Isaiah Davis, et al.
Pageof 67

Showing results (431-440 of 663) with videos related to

Sort By:
Pageof 67
Immunity|November 29, 2024
Cognate antigen engagement induces HIV-1 expression in latently infected CD4<sup>+</sup> T cells from people on long-term antiretroviral therapyMilica Moskovljevic, Filippo Dragoni, Nathan L Board, et al.
Ebiomedicine|March 1, 2021
Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latencyJennifer M Zerbato, Georges Khoury, Wei Zhao, et al.
Nature Immunology|January 26, 2024
Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cellsNathan L Board, Zhe Yuan, Fengting Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2012
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?Amy C Justice, Matthew S Freiberg, Russ Tracy, et al.
Plos One|December 30, 2014
The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trialMa Somsouk, Richard M Dunham, Michelle Cohen, et al.
The Journal of Infectious Diseases|September 12, 2022
Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVIDMichael J Peluso, Anthea Mitchell, Chung Yu Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative studyEdda I Santiago-Rodriguez, Andres Maiorana, Michael J Peluso, et al.
Frontiers in Immunology|August 15, 2022
Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIVMichael L Freeman, Brian M Clagett, Daniela Moisi, et al.
The Journal of Infectious Diseases|April 29, 2017
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral TherapyGabriela Khoury, Rémi Fromentin, Ajantha Solomon, et al.
Nature Medicine|June 25, 2013
Association of HLA-DRB1-restricted CD4⁺ T cell responses with HIV immune controlSrinika Ranasinghe, Sam Cutler, Isaiah Davis, et al.
Pageof 67